Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
D. Cadavid, Michelle Mellion, Raymond Hupperts, Keith R. Edwards, Peter A. Calabresi, Jelena Drulović, G. Giovannoni, Hans Peter Hartung, Douglas L. Arnold, Elizabeth Fisher, Richard Rudick, Sha Mi, Yi Chai, Jie Li, Y. Zhang, Wenting Cheng, Lei Xu, Bing Zhu, Susan M. Green, Ih ChangA. Deykin, Sarah I. Sheikh, Eduardo Agüera Morales, Abdullatif Al Khedr, R. Ampapa, Rafael Arroyo, Martin Belkin, Robert Bonek, Alexey Boyko, Ruggero Capra, D. Centonze, Pierre Clavelou, Marc Debouverie, Jelena Drulovic, K. Edwards, N. Evangelou, Evgeniy Evdoshenko, O. Fernández, Victoria Fernández Sánchez, Mark Freedman, Steven Freedman, Waldemar Fryze, Antonio Garcia-Merino, Mira Gavric-Kezic, A. Ghezzi, Olivier Gout, L. Grimaldi, B. Hendin, H. Hertmanowska, Rogier Hintzen, P. Hradilek, Jan Ilkowski, Evelina Ivashinenkova, Guillermo Izquierdo, Francois Jacques, G. Jakab, F. Khabirov, Gabriela Klodowska-Duda, Samuel Komoly, Smiljana Kostic, I. Kovarova, Marcelo Kremenchuzky, Christopher Laganke, Yves LaPierre, Maciej Maciejowski, Francois Grand Maison, Girolama Alessandra Marfia, Sergio Martínez Yélamos, Eva Meluzinova, Xavier Montalban, Ronald Murray, Robert Naismith, S. Newsome, Viet Nguyen, D. Oreja, Gabriel Pardo, E. Pasechnik, Francesco Patti, Andrzej Potemkowski, S. Prokopenko, Peiqing Qian, Alfredo Rodríguez-Antigüedad, Howard Rossman, Csilla Rozsa, Fernando Sánchez López, Krzysztof Selmaj, Eli Silber, Adam Stepien, Anna Stepniewska, Maciej Swiat, Gordana Toncev, A. Tourbah, Tatyana Trushnikova, Antonio Uccelli, M. Vachova, Martin Valis, Laszlo Vecsei, Sandrine Wiertlewski, M. Zaffaroni, Tomasz Zielinski
Dive into the research topics of 'Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.